Interferon Alfa Injection

29 November 2007

Products Affected - Description

Roferon-A, Roche

Reason for the Shortage

Roche states that Roferon-A was discontinued October, 2007 due to business reasons. There are no supplies of the 3 million unit prefilled syringes. Distribution of the 6 million unit and 9 million unit prefilled syringes will continue until December 31, 2007. There are currently no other suppliers of interferon alfa-2a, recombinant.

Estimated Resupply Dates

• Interferon alfa-2a, recombinant is discontinued.
• Interferon alfa-2b, recombinant, injection (Intron A, Schering) is not affected by this shortage.

Related Shortages

• Bleomycin Injection
• Carmustine Injection— Resolved
• Cisplatin Injection— Resolved
• Cyclophosphamide for Injection— Resolved
• Cyclophosphamide Tablets— Resolved
• Cytarabine Injection
• Doxorubicin Injection— Resolved
• Epirubicin Injection— Resolved
• Fluorouracil Injection— Resolved
• Hydroxyurea Capsules— Resolved
• Ifosfamide— Resolved
• Leuprolide Implant— No Longer Available
• Mechlorethamine Hydrochloride Injection— Resolved
• Melphalan Injection Injection— Resolved
• Methotrexate Injection
• Mitomycin Injection
• Paclitaxel Injection— Resolved
• Procarbazine Capsules— Resolved
• Thiotepa Injection
• Vinblastine Injection
• Vincristine Injection— Resolved

Updated

November 29, 2007; March 12, 2007; February 1, 2007; November 29, October 27, and October 9, 2006; University of Utah, Drug Information Service

Back to Drug Shortage Product Bulletins